Icon Advisers Inc Corcept Therapeutics Inc Transaction History

Icon Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 01, 2020	SELL	$10.11 - $14.04 $472,137 - $655,668	-46,700 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$12.06 - $16.96 $184,518 - $259,488	-15,300 Reduced 24.68%	46,700 $565,000
Q2 2019 Aug 02, 2019	SELL	$9.78 - $12.76 $534,966 - $697,972	-54,700 Reduced 46.87%	62,000 $691,000
Q4 2018 Feb 04, 2019	BUY	$11.29 - $17.19 $869,329 - $1.32 Million	77,000 Added 193.95%	116,700 $1.56 Million
Q3 2018 Nov 05, 2018	BUY	$12.27 - $15.65 $487,119 - $621,305	39,700 New	39,700 $557,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.